Australia markets open in 9 hours 3 minutes

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
51.23+0.63 (+1.25%)
As of 10:56AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close50.60
Open50.01
Bid50.96 x 200
Ask51.49 x 100
Day's range49.75 - 52.12
52-week range24.83 - 54.50
Volume183,717
Avg. volume457,764
Market cap2.611B
Beta (5Y monthly)1.01
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

    SAN JOSE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on Friday, May 3, 2024, at the Grand Hyatt Hotel in San Antonio, TX at the American Urological Association Annual Meeting from 8:00am to 9:30am Central Time. Members of PROCEPT BioRobotics’ management team presenting include: Re

  • GlobeNewswire

    PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

    SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2024 after market close on Wednesday, May 1, 2024. The Company’s management will host a corresponding conference call beginning at 8:00 a.m. Eastern Time. Investors interested in listening to the

  • GlobeNewswire

    PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

    SAN JOSE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2023. Recent Highlights Total revenue of approximately $43.6 million for the fourth quarter of 2023, an increase of 83% compared to the prior year periodU.S. system and rental revenue of $16.6 million for